Author:
Li Zhen-Hang,Guan Yan-Lei,Liu Qiang,Wang Yao,Cui Run,Wang Yun-Jie
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica 131, 803–820,
https://doi.org/10.1007/s00401-016-1545-1
(2016).
2. Xing, Z., You, R. X., Li, J., Liu, Y. & Cao, D. R. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Clin Neuroradiol 24, 329–336,
https://doi.org/10.1007/s00062-013-0255-5
(2014).
3. Liang, R. et al. Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis. Int J Clin Exp Med 7, 5573–5577 (2014).
4. Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell 17, 98–110,
https://doi.org/10.1016/j.ccr.2009.12.020
(2010).
5. Kuo, L. T. et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors. Cancer Med 5, 1830–1839,
https://doi.org/10.1002/cam4.762
(2016).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献